Dollard des Ormeaux, Canada

Patrick Roy

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 6.3

ph-index = 10

Forward Citations = 912(Granted Patents)


Location History:

  • Pierrefonds, CA (1995 - 1999)
  • Dollard Des Ormeaux, CA (1995 - 2013)
  • Dollard des Omeaux, CA (2012 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Innovations by Patrick Roy: A Pioneer in Kinase Inhibition

Introduction

Patrick Roy, based in Dollard des Ormeaux, Canada, has made significant strides in the field of pharmaceutical inventions. With a remarkable portfolio of 24 patents, Roy has demonstrated his commitment to developing innovative solutions that address critical health issues.

Latest Patents

Among his latest contributions are two noteworthy inventions. The first patent involves "Tricyclic compounds useful as inhibitors of kinases," which focuses on specific IκB kinases and JAK family members. This invention presents a solution for treating patients with myeloproliferative disorders, cancer, or diseases mediated by NF-κB. The second patent addresses "renin inhibitors," detailing piperidine-based compounds with carboxylate or carboxylic acid terminal groups. These inhibitors show promise for treating cardiovascular events and renal insufficiency.

Career Highlights

Patrick Roy has been associated with reputable companies, including Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His work highlights his expertise in biopharmaceutical research and development, where he has been instrumental in driving innovations that enhance patient care.

Collaborations

Throughout his career, Roy has worked with notable colleagues like Yves Leblanc and Cheuk K Lau. These collaborations have further enriched his research endeavors, leading to advancements in therapeutics that benefit a wide range of patients.

Conclusion

In conclusion, Patrick Roy’s inventive contributions continue to shape the landscape of pharmaceutical innovations. His extensive experience and collaboration with leading professionals in the field underscore his role as a key figure in developing effective treatments for serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…